Did You Know?

GreACTRIMS.jpgetings from the ACTRIMS Forum 2018! This 3-day meeting brings together almost 1,000 MS-focused health care professionals, such as researchers and neurologists, and lets them share their latest research findings. I wanted to share with you a few of the amazing things I’ve learned so far at this inspiring meeting.
 
There are plenty of lectures from experts who were invited to review the latest research on specific topics. Then there are also presentations by investigators who submitted summaries of their results to the meeting organizers, for possible acceptance as either lectures or as posters. I happen to love poster sessions. Kind of like a science fair, you can go up to researchers and their posters and talk to them about their work.
 
The topics of the posters at this meeting are so wide-ranging in their themes that I thought I’d share some of the random things I’ve gleaned so far. Did you know? (I didn’t…)
  • That people with MS who get care from neurologists at MS Centers are much more likely to receive disease-modifying therapy than people who get their MS care from a primary care physician? This is according to a new study by researchers from Temple University (Read more here).
  • People in our social network can influence so many aspects of our lives, like our diets, physical activity levels and even infections? According to researchers at Columbia University and collaborators studying people with close relatives with MS, having a social network that includes a high proportion of people who don’t go to doctors regularly is strongly linked to self-reported disabilities (Learn more here).
  • That African-Americans with MS experience faster nerve degeneration—seen at the back of the eye—than Caucasians with MS? The team from Johns Hopkins and collaborators suggest this raises the question of whether this population may benefit from more aggressive therapy (Find out more here).
  • That a sample of MS doctors who were surveyed rarely use confirmed methods to detect cognitive issues or depression in their patients with MS? Furthermore, they don’t necessarily refer them to neuropsychologists, even if they detect mood or cognitive changes. This was reported by researchers from the University of South Florida (Read more here).
There are many other studies being presented, including lots about advances toward repairing myelin that’s damaged by MS. You’ll see more from our team in the coming days. In the meantime, feel free to have a look around yourself–the online abstracts (scientific summaries) of the ACTRIMS Forum presentations and posters are up and open for all to explore.

Also, check out our complete recap from ACTRIMS!
Tags Research, Symptoms, Treatment      1 Appreciate this
Claude

Claude Schofield, PhD

Dr. Claude Schofield is Director of Discovery Research at the National MS Society. He began his career as a biomedical researcher, focused on the nervous system. He research has been published in Journal of Neuroscience, Proceedings of the National Academies of Science, and Neural Development.